SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-22-002713
Filing Date
2022-02-15
Accepted
2022-02-15 16:21:51
Documents
13
Period of Report
2022-02-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K blcm-20220214.htm   iXBRL 8-K 32683
  Complete submission text file 0001628280-22-002713.txt   194328

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blcm-20220214.xsd EX-101.SCH 2156
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT blcm-20220214_def.xml EX-101.DEF 14380
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blcm-20220214_lab.xml EX-101.LAB 27854
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blcm-20220214_pre.xml EX-101.PRE 14917
7 EXTRACTED XBRL INSTANCE DOCUMENT blcm-20220214_htm.xml XML 10774
Mailing Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098
Business Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36783 | Film No.: 22639479
SIC: 2834 Pharmaceutical Preparations